Skip to main content

PharmacoEconomics

Ausgabe 9/2014

Inhalt (9 Artikel)

Review Article

HTA Agencies Facing Model Biases: The Case of Type 2 Diabetes

Véronique Raimond, Jean-Michel Josselin, Lise Rochaix

Review Article

The Burden of Disease in Rheumatoid Arthritis

Till Uhlig, Rikke H. Moe, Tore K. Kvien

Review Article

Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Myeloid Leukaemia: A Review and Summary of Challenges

Kevin Marsh, Peng Xu, Panagiotis Orfanos, Agnes Benedict, Kamal Desai, Ingolf Griebsch

Open Access Systematic Review

The Economic Burden of Head and Neck Cancer: A Systematic Literature Review

Erika Wissinger, Ingolf Griebsch, Juliane Lungershausen, Talia Foster, Chris L. Pashos

Systematic Review

Discrete Choice Experiments in Health Economics: A Review of the Literature

Michael D. Clark, Domino Determann, Stavros Petrou, Domenico Moro, Esther W. de Bekker-Grob

Original Research Article

Cost Effectiveness of Darunavir/ritonavir Combination Antiretroviral Therapy for Treatment-Naive Adults with HIV-1 Infection in Canada

Anita J. Brogan, Erik Smets, Josephine A. Mauskopf, Sarah A. L. Manuel, Ines Adriaenssen

Original Research Article

Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain

Antonio Gómez-Outes, Cristina Avendaño-Solá, Ana Isabel Terleira-Fernández, Emilio Vargas-Castrillón